Hospital Universitario Doctor Peset
Valencia, València 46017
2 studies enrolling now · 2 studies all time
What they study most
Multiple Myeloma
Studies at this site
- A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant — Recruiting now
- Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) — Recruiting now